You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.

regorafenib

( RE-goe-RAF-e-nib )
Funding:
Exceptional Access Program
  • regorafenib - For the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) in patients who have had disease progression on, or intolerance to,
    imatinib and sunitinib, according to specific criteria
  • regorafenib - For the treatment of hepatocellular carcinoma according to clinical criteria
Other Name(s): Stivarga®
Appearance: tablet

Patient Info Sheet

Oct 2020

What it is used for

For treating colorectal cancer, gastrointestinal stromal tumours (GIST) or liver cancer in patients who have received treatment(s) before. 



You might also be interested in